FDA Says Celebrity Rx Drug Endorsements on Social Media Must Include Information on Risks
FDA last week warned drugmaker Duchesnay that Kim Kardashian West's Instagram post promoting its morning sickness drug Diclegis did not adequately disclose risk information. According to FDA, the post should have included information about the treatment's side effects, including possible complications when combined with alcohol and other medications that cause drowsiness, such as sleeping aids or some pain relievers. FDA has called for a "corrective piece" to be disseminated "using the same media."
- "FDA Threatens To Pull Drug After Kim Kardashian Endorsement" (Ferris, The Hill, 8/11).
- "FDA Issues Warning Over Kim Kardashian's Drug Promotions" (Perrone, AP/Miami Herald, 8/11).